Long-term and short-term oral anticoagulation therapies were equivalent for venous thromboembolism.

P a t i e n t s 736 patients (mean age 59 y, 53% women) who had symptomatic PDVT or pulmonary embolism, or both, or symptomatic CDVT confirmed by objective diagnostic tests. Exclusion criteria included pregnancy, breastfeeding, vena cava filter implantation, surgical thrombectomy, free-floating thrombus in the inferior vena cava, active cancer or malignant hematologic disease, or a previous venous thromboembolism. 97% of patients completed the study.